Iovance Biotherapeutics was Granted Fast Track Designation for LN-145 for Cervical Cancer
Go back to Iovance Biotherapeutics was Granted Fast Track Designation for LN-145 for Cervical Cancer| (NASDAQ: IOVA) | Delayed: 10.45 -0.19 (1.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.64 | 52 Week High | $ | |||
| Open | $10.69 | 52 Week Low | $ | |||
| Day High | $10.85 | P/E | N/A | |||
| Day Low | $10.37 | EPS | $ | |||
| Volume | 5,050,239 | |||||
